Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pathology, Surgical | 4 | 2023 | 151 | 2.910 |
Why?
|
| Laboratories | 4 | 2022 | 458 | 1.790 |
Why?
|
| Cytodiagnosis | 4 | 2022 | 447 | 1.590 |
Why?
|
| Quality Assurance, Health Care | 6 | 2022 | 2169 | 1.480 |
Why?
|
| Diagnostic Errors | 8 | 2023 | 1265 | 1.450 |
Why?
|
| Specimen Handling | 5 | 2022 | 702 | 1.260 |
Why?
|
| Medical Errors | 4 | 2022 | 1263 | 1.110 |
Why?
|
| Laboratories, Hospital | 2 | 2019 | 192 | 1.080 |
Why?
|
| Truth Disclosure | 2 | 2022 | 434 | 1.050 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 2022 | 101 | 0.760 |
Why?
|
| False Positive Reactions | 2 | 2019 | 957 | 0.660 |
Why?
|
| Histocytological Preparation Techniques | 1 | 2019 | 33 | 0.660 |
Why?
|
| Total Quality Management | 1 | 2020 | 265 | 0.650 |
Why?
|
| Pathology, Clinical | 1 | 2022 | 376 | 0.620 |
Why?
|
| Frozen Sections | 1 | 2019 | 153 | 0.620 |
Why?
|
| Histological Techniques | 1 | 2016 | 194 | 0.530 |
Why?
|
| Quality Improvement | 4 | 2021 | 3801 | 0.530 |
Why?
|
| Chondrosarcoma | 1 | 2018 | 296 | 0.520 |
Why?
|
| Clinical Laboratory Information Systems | 1 | 2016 | 109 | 0.510 |
Why?
|
| Checklist | 2 | 2020 | 827 | 0.500 |
Why?
|
| Pathology | 1 | 2018 | 270 | 0.480 |
Why?
|
| Thyroid Gland | 2 | 2020 | 1170 | 0.460 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2018 | 610 | 0.430 |
Why?
|
| Lymphatic Metastasis | 2 | 2018 | 2915 | 0.410 |
Why?
|
| Communication | 2 | 2022 | 3873 | 0.370 |
Why?
|
| Models, Theoretical | 1 | 2020 | 3575 | 0.310 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2009 | 1085 | 0.300 |
Why?
|
| Molecular Targeted Therapy | 2 | 2018 | 2811 | 0.290 |
Why?
|
| Genes, BRCA2 | 1 | 2009 | 601 | 0.260 |
Why?
|
| Anti-Glomerular Basement Membrane Disease | 2 | 2012 | 41 | 0.250 |
Why?
|
| Kidney | 4 | 2013 | 7048 | 0.230 |
Why?
|
| Kidney Transplantation | 3 | 2013 | 4235 | 0.210 |
Why?
|
| Complement C4b | 1 | 2013 | 126 | 0.210 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2018 | 5315 | 0.200 |
Why?
|
| Plasma Cell Granuloma, Pulmonary | 1 | 2010 | 12 | 0.180 |
Why?
|
| Adenovirus Infections, Human | 1 | 2011 | 73 | 0.180 |
Why?
|
| Planning Techniques | 1 | 2020 | 82 | 0.180 |
Why?
|
| Pancreas Transplantation | 1 | 2011 | 197 | 0.170 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2023 | 2510 | 0.170 |
Why?
|
| Humans | 31 | 2023 | 761578 | 0.170 |
Why?
|
| Cryptococcosis | 1 | 2010 | 104 | 0.170 |
Why?
|
| Fibrocystic Breast Disease | 1 | 2009 | 103 | 0.170 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2013 | 335 | 0.170 |
Why?
|
| Lupus Nephritis | 1 | 2012 | 317 | 0.160 |
Why?
|
| North Carolina | 1 | 2019 | 325 | 0.160 |
Why?
|
| Ecosystem | 1 | 2023 | 490 | 0.150 |
Why?
|
| Cytological Techniques | 1 | 2020 | 218 | 0.150 |
Why?
|
| Organizational Objectives | 1 | 2020 | 426 | 0.150 |
Why?
|
| Intraoperative Period | 1 | 2019 | 510 | 0.150 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2009 | 114 | 0.150 |
Why?
|
| Esophagitis | 1 | 2009 | 164 | 0.150 |
Why?
|
| Carcinoma | 2 | 2019 | 2330 | 0.140 |
Why?
|
| Hospitals, University | 1 | 2019 | 564 | 0.140 |
Why?
|
| Gastroscopy | 1 | 2009 | 211 | 0.140 |
Why?
|
| Polyps | 1 | 2009 | 200 | 0.140 |
Why?
|
| Adenoviridae | 1 | 2011 | 1085 | 0.140 |
Why?
|
| Biopsy, Needle | 2 | 2018 | 1626 | 0.140 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 13382 | 0.130 |
Why?
|
| Endometrium | 1 | 2019 | 403 | 0.130 |
Why?
|
| Abdominal Pain | 1 | 2013 | 1071 | 0.130 |
Why?
|
| Risk Management | 1 | 2019 | 558 | 0.130 |
Why?
|
| Fever | 1 | 2013 | 1618 | 0.120 |
Why?
|
| Workflow | 2 | 2017 | 851 | 0.120 |
Why?
|
| Barrett Esophagus | 1 | 2009 | 492 | 0.120 |
Why?
|
| Eosinophilia | 1 | 2009 | 560 | 0.110 |
Why?
|
| Watchful Waiting | 1 | 2018 | 491 | 0.110 |
Why?
|
| Mutation | 1 | 2018 | 30054 | 0.110 |
Why?
|
| Graft Rejection | 2 | 2013 | 4446 | 0.100 |
Why?
|
| DNA Mutational Analysis | 2 | 2018 | 4111 | 0.100 |
Why?
|
| Efficiency, Organizational | 1 | 2016 | 695 | 0.100 |
Why?
|
| Hospitals, Teaching | 1 | 2016 | 1156 | 0.100 |
Why?
|
| DNA, Neoplasm | 1 | 2017 | 1745 | 0.100 |
Why?
|
| Gastroesophageal Reflux | 1 | 2009 | 819 | 0.090 |
Why?
|
| Female | 12 | 2022 | 392688 | 0.090 |
Why?
|
| Kidney Failure, Chronic | 1 | 2013 | 2472 | 0.090 |
Why?
|
| Peptide Fragments | 1 | 2013 | 5112 | 0.090 |
Why?
|
| Gastrointestinal Diseases | 1 | 2009 | 1200 | 0.090 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2012 | 2155 | 0.090 |
Why?
|
| Acute Kidney Injury | 1 | 2012 | 1924 | 0.090 |
Why?
|
| Endometrial Neoplasms | 1 | 2019 | 1366 | 0.080 |
Why?
|
| Patient Care Team | 1 | 2020 | 2521 | 0.080 |
Why?
|
| Adenoma | 1 | 2009 | 2163 | 0.080 |
Why?
|
| Stomach Neoplasms | 1 | 2009 | 1459 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2009 | 11742 | 0.080 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 2578 | 0.080 |
Why?
|
| Breast Neoplasms | 2 | 2009 | 21019 | 0.070 |
Why?
|
| Retrospective Studies | 4 | 2023 | 80646 | 0.070 |
Why?
|
| Referral and Consultation | 1 | 2019 | 3600 | 0.070 |
Why?
|
| Diagnosis, Differential | 4 | 2012 | 12973 | 0.060 |
Why?
|
| Transplantation, Autologous | 1 | 2009 | 2115 | 0.060 |
Why?
|
| Transplantation, Homologous | 2 | 2013 | 4807 | 0.060 |
Why?
|
| Mastectomy, Segmental | 1 | 2009 | 955 | 0.060 |
Why?
|
| Genetic Testing | 1 | 2017 | 3537 | 0.060 |
Why?
|
| Boston | 1 | 2016 | 9326 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 20099 | 0.050 |
Why?
|
| Immunohistochemistry | 3 | 2013 | 11076 | 0.050 |
Why?
|
| Ovarian Neoplasms | 1 | 2019 | 4878 | 0.050 |
Why?
|
| Pedigree | 1 | 2009 | 4542 | 0.050 |
Why?
|
| Radiography | 2 | 2012 | 6965 | 0.050 |
Why?
|
| Prognosis | 2 | 2018 | 29629 | 0.050 |
Why?
|
| Hematuria | 1 | 2012 | 233 | 0.050 |
Why?
|
| Cryptococcus gattii | 1 | 2010 | 2 | 0.050 |
Why?
|
| Glomerulonephritis | 1 | 2012 | 331 | 0.040 |
Why?
|
| Time Factors | 2 | 2019 | 39970 | 0.040 |
Why?
|
| Male | 8 | 2022 | 360841 | 0.040 |
Why?
|
| Pulmonary Alveoli | 1 | 2012 | 652 | 0.040 |
Why?
|
| Fluconazole | 1 | 2010 | 157 | 0.040 |
Why?
|
| Middle Aged | 4 | 2022 | 220917 | 0.040 |
Why?
|
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2012 | 225 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2023 | 54423 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2011 | 15633 | 0.040 |
Why?
|
| Edema | 1 | 2012 | 766 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 8528 | 0.040 |
Why?
|
| Bone Neoplasms | 1 | 2009 | 2529 | 0.030 |
Why?
|
| Adult | 5 | 2018 | 221200 | 0.030 |
Why?
|
| Aged | 5 | 2019 | 169308 | 0.030 |
Why?
|
| Observer Variation | 1 | 2013 | 2606 | 0.030 |
Why?
|
| Renal Insufficiency | 1 | 2012 | 809 | 0.030 |
Why?
|
| Genetic Techniques | 1 | 2009 | 428 | 0.030 |
Why?
|
| Vitamin B 12 | 1 | 2009 | 524 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 2009 | 1900 | 0.030 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2013 | 1048 | 0.030 |
Why?
|
| Antifungal Agents | 1 | 2010 | 753 | 0.030 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2010 | 1118 | 0.030 |
Why?
|
| Genetic Counseling | 1 | 2009 | 627 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2012 | 5036 | 0.030 |
Why?
|
| Antibodies | 1 | 2012 | 2418 | 0.030 |
Why?
|
| Respiratory Insufficiency | 1 | 2012 | 1230 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2012 | 2118 | 0.030 |
Why?
|
| Lung | 2 | 2012 | 10002 | 0.030 |
Why?
|
| Thyroidectomy | 1 | 2009 | 908 | 0.030 |
Why?
|
| Esophagus | 1 | 2009 | 1033 | 0.030 |
Why?
|
| Causality | 1 | 2009 | 1242 | 0.030 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2009 | 874 | 0.030 |
Why?
|
| Lung Diseases | 1 | 2012 | 1909 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 2009 | 1530 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3779 | 0.020 |
Why?
|
| Biopsy | 1 | 2013 | 6766 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2012 | 3424 | 0.020 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2017 | 1626 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2017 | 1745 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2017 | 2425 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2017 | 5247 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2009 | 5971 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 5336 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2017 | 4514 | 0.010 |
Why?
|
| Comorbidity | 1 | 2009 | 10508 | 0.010 |
Why?
|
| Young Adult | 2 | 2010 | 59254 | 0.010 |
Why?
|
| Prevalence | 1 | 2009 | 15732 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 7391 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 20569 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 58983 | 0.010 |
Why?
|
| Adolescent | 1 | 2009 | 88323 | 0.010 |
Why?
|
Concepts
(153)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(25)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_